Sulforaphane protects hearts from early injury after experimental transplantation

Annals of Transplantation

Volumn 18, Issue 1, 2013, Pages 558-566

  Li, Zhanqing ^a   Galli, Uwe ^a   Becker, Luis E ^a   Bruns, Helge ^a   Nickkolgh, Arash ^a   Hoffmann, Katrin ^a   Karck, Matthias ^a   Schemmer, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Heart transplantation; Ischemia reperfusion injury; Regeneration; Sulforaphane

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CREATINE KINASE; CREATINE KINASE ISOENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; SULFORAPHANE; TROPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE INCREASE; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM; SURVIVAL;

ANIMALS; HEART; HEART TRANSPLANTATION; ISOTHIOCYANATES; MALE; MYOCARDIUM; RATS; RATS, INBRED LEW; REPERFUSION INJURY;

EID: 84887236178     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.889342     Document Type: Article

References (26)

1. Stehlik J, Edwards LB, Kucheryavaya AY et al: The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. J Heart Lung Transplant, 2010; 29(10): 1089-103
2. http://www.bqs-institut.de/
3. Iyer A, Kumarasinghe G, Hicks M et al: Primary graft failure after heart transplantation. J Transplant, 2011; 2011: 175768
4. Marasco SF, Kras A, Schulberg E et al: Impact of warm ischemia time on survival after heart transplantation. Transplant Proc, 2012; 44(5): 1385-89
5. Tanito M, Masutani H, Kim YC et al: Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. InVest Opthalmol Vis Sci, 2005; 46: 979-87
6. Yoon H-Y, Kang N-I, Lee H-K et al: Sulforaphane protects kidney against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem Pharmacol, 2008; 2214-23
7. Thimmulappa RK, Mai KH, Srisuma S et al: Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res, 2002; 62(18): 5196-203
8. Mukherjee S, Gangopadhyay H, Das DK: Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J Agric Food Chem, 2008; 56(2): 609-17
9. Lee JS, Surh YJ: Nrf2 as a novel molecular target for chemoprevention. Cancer Lett, 2005; 224(2): 171-84
10. Kallifatidis G, Rausch V, Baumann B et al: Sulforaphane targets pancreatic tumor-initiating cells by NF-kappaB induced antiapoptic signalling. Gut, 2009: 58(7): 949-63
11. Jeong JK, Moon MH, Seo JS et al: Sulforaphane blocks hypoxia-mediated resistance to TRAIL induced tumor cell death. Mol Med Rep, 2011; 4(2): 325-30
12. Facchini A, Stanic I, Cetrullo S et al: Sulforaphane protects human chondrocytes against cell death induced by various stimuli. J Cell Physiol, 2011; 226(7): 1771-79
13. Shan Y, Zhao R, Geng W et al: Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage Cardiovasc. Toxicol, 2010; 10(2): 139-45
14. Schemmer P, Thies JC, Koeppel TA et al: Influence of nitric oxide on graft rejection. An experimental study in animals. Gastroenterology, 1996; 110(4): 1314
15. Koeppel TA, Thies JC, Schemmer P et al: Inhibition of nitric oxide synthesis in ischemia/ reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol, 1997; 27(1): 163-69
16. Koeppel TA, Mihaljevic N, Kraenzlin B et al: Enhanced iNOS gene expression in the steatotic rat liver after normothermic ischemia. Eur Surg Res, 2007; 39(5): 303-11
17. Zhang XL, Yan ZW, Sheng WW et al: Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase. Mol Cell Biochem, 2011; 358(1-2): 287-95
18. Ono K, Lindsey ES: Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg, 1969; 57: 225-29
19. Kuznetsov AV, Schneeberger S, Seiler R et al: Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion. Am J Physiol Heart Circ Physiol, 2004; 286(5): H1633-41
20. Zou H, Henzel WJ, Liu X et al: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 1997; 90(3): 405-13
21. Agosto M, Azrin M, Singh K et al: Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation. J Am Coll Cardiol, 2011; 57(2): 220-21
22. Bergeron M, Yu AY, Solway KE et al: Induction of hypoxia-inducible factor-1 (HIF-1a) and its target genes following focal ischaemia in rat brain. Eur J Neurosci, 1999; 11(12): 4159-70
23. Hu R, Dai A, Tan S: Hypoxia-inducible factor 1 alpha upregulates the expression of inducible nitric oxide synthase gene in pulmonary arteries of hyposic rat. Chin Med J (Engl), 2002; 115(12): 1833-37
24. Firth JD, Ebert BL, Ratcliffe PJ: Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J Biol Chem, 1995; 270(36): 21021-27
25. Wildhirt SM, Suzuki H, Wolf WP et al: S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction. Biochem Biophys Res Commun,1996; 227(2): 328-33
26. Lewis NP, Tsao PS, Rickenbacher PR et al: Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation, 1996; 93(4): 720-29